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Background:  No  information  is  currently  available  on  the  prognostic  signiﬁcance  of  the  number
of leads  with  fragmented  QRS  (fQRS).  The  objective  of  the  study  was  to  clarify  the  prognostic
signiﬁcance  of  the  number  of  leads  with  fQRS  in  prior  myocardial  infarction  (MI).
Methods  and  results:  We  retrospectively  examined  170  patients  with  prior  MI.  The  primary  end
point was  cardiac  death  or  hospitalization  for  heart  failure.  During  a  mean  follow-up  period
of 6.4  ±  2.9  years,  37  patients  developed  the  primary  end  point.  Univariate  Cox  proportional
hazards  regression  analyses  showed  that  age,  male  gender,  chronic  kidney  disease,  anterior
wall MI,  number  of  leads  with  fQRS,  left  ventricular  ejection  fraction,  loop  diuretic  use,  and
spironolactone  use  were  signiﬁcantly  associated  with  the  primary  end  point.  A  multivariate
Cox proportional  hazards  regression  analysis  selected  age  (hazard  ratio  [HR]  1.09,  95%  conﬁ-
dence interval  [CI]  1.04—1.14,  p  <  0.001)  and  the  number  of  leads  with  fQRS  (HR  1.33,  95%  CI
1.11—1.60, p  =  0.002)  as  predictors  of  the  primary  end  point.  A  receiver  operating  characteristic
curve analysis  showed  that  the  presence  of  ≥3  leads  with  fQRS  was  most  useful  for  distinguish-
ing between  patients  with  and  without  the  primary  end  point.  A  Kaplan—Meier  analysis  showed
a lower  primary  event-free  rate  in  patients  with  ≥3  leads  with  fQRS  than  in  those  with  <3  leads
with fQRS.
Conclusions:  The  number  of  leads  with  fQRS,  especially  the  presence  of  ≥3  leads  with  fQRS,  is
f  car iac  death  or  hospitalization  for  heart  failure  in  patients  withan independent  predictor  o
prior MI.
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uNumber  of  leads  with  fragmented  QRS  in  MI  
Introduction
Regional  myocardial  scars  have  been  suggested  to  be  associ-
ated  with  alterations  in  QRS  morphology,  leading  to  terminal
conduction  delay  or  fragmentation  of  the  QRS  complexes  on
the  12-lead  electrocardiogram  [1,2]. Das  et  al.  [3]  demon-
strated  that  the  presence  of  fragmented  QRS  (fQRS),  deﬁned
as  an  additional  R  wave  (R’),  notching  of  the  R  wave,  notch-
ing  of  the  downstroke  or  upstroke  of  the  S  wave,  or  the
presence  of  >1R’  in  ≥2  contiguous  leads  corresponding  to  a
major  coronary  artery  territory  on  the  12-lead  electrocar-
diogram,  is  associated  with  myocardial  scars  on  myocardial
perfusion  imaging  in  patients  with  coronary  artery  disease.
Furthermore,  the  presence  of  fQRS  has  been  shown  to  pre-
dict  adverse  outcomes  in  patients  with  coronary  artery
disease  [4],  acute  coronary  syndrome  [5],  prior  myocardial
infarction  (MI)  showing  resolved  Q  waves  [6],  and  ischemic
or  non-ischemic  cardiomyopathy  [7].  However,  no  informa-
tion  is  currently  available  about  the  prognostic  signiﬁcance
of  the  number  of  leads  with  fQRS.  We  hypothesized  that  the
number  of  leads  with  fQRS  would  be  associated  with  car-
diac  death  or  hospitalization  for  heart  failure  in  patients




Eligible  patients  with  prior  MI  (>6  months)  who  had
undergone  diagnostic  or  follow-up  coronary  angiography
together  with  left  ventriculography  at  Oita  University  Hospi-
tal  between  January  2000  and  December  2006  were  enrolled
in  this  retrospective  study.  The  exclusion  criteria  were  as
follows:  (1)  critical  stenotic  lesions  in  the  major  coro-
nary  arteries  requiring  revascularization;  (2)  concomitant
myocardial  diseases  or  valvular  heart  diseases  requiring
cardiac  surgery;  (3)  bundle  branch  block;  and  (4)  life-
threatening  non-cardiac  diseases.  A  prior  MI  was  deﬁned
as  follows:  (1)  a  history  of  acute  MI,  which  was  identi-
ﬁed  by  a  rise  in  serum  creatine  kinase  together  with  ≥1
of  the  following  conditions:  ischemic  chest  pain  lasting
≥20  min;  electrocardiographic  changes  indicative  of  new
myocardial  ischemia;  development  of  abnormal  Q  waves;
total  or  subtotal  occlusion  of  the  coronary  artery  on  coro-
nary  angiograms;  or  cardiac  imaging  evidence  of  new  loss
of  viable  myocardium  or  new  regional  wall  motion  in  the
left  ventricle;  or  (2)  irrespective  of  a  history  of  ischemic
chest  pain  lasting  ≥20  min,  abnormal  Q  waves  and  imaging
evidence  of  loss  of  viable  myocardium  in  the  left  ventricle
in  the  absence  of  a  non-ischemic  cause.  The  study  protocol
was  approved  by  the  ethics  committee  at  our  institution.
Data  collection  and  primary  end  point
The  following  data  at  baseline  were  collected  from  medical
records:  age,  gender,  body  mass  index,  presence  or  absence
of  current  smoking,  hypertension,  diabetes  mellitus,  dys-
lipidemia,  chronic  kidney  disease,  prior  percutaneous





ultivessel  disease,  left  ventricular  (LV)  ejection  frac-
ion  obtained  from  left  ventriculography,  and  medications.
ypertension  was  deﬁned  as  systolic  blood  pressure
140  mmHg,  diastolic  blood  pressure  ≥90  mmHg,  or  treat-
ent  with  antihypertensive  drugs.  Diabetes  mellitus  was
eﬁned  as  fasting  plasma  glucose  ≥126  mg/dl,  plasma  glu-
ose  ≥200  mg/dl  at  2  h  after  a  75  g  glucose  load,  or
reatment  with  hypoglycemic  agents.  Chronic  kidney  dis-
ase  was  deﬁned  as  an  estimated  glomerular  ﬁltration
ate  <60  ml/min/1.73  m2. The  estimated  glomerular  ﬁltra-
ion  rate  was  calculated  by  the  equation  proposed  by  the
apanese  Society  of  Nephrology  [8].  Multivessel  coronary
isease  was  deﬁned  as  the  presence  of  luminal  diameter
tenosis  >50%  in  ≥2  coronary  arteries.
The  primary  end  point  was  cardiac  death  or  hospital-
zation  for  heart  failure  on  or  before  December  31,  2010.
ardiac  death  included  sudden  death.  Cardiac  death  or  hos-
italization  for  heart  failure  was  documented  from  hospital
edical  records  and  information  obtained  by  patients  or
atients’  relatives  using  a  direct  or  telephone  interview.
lectrocardiography
 standard  12-lead  electrocardiogram  was  recorded  at  a
aper  speed  of  25  mm/s,  an  ampliﬁcation  of  10  mm  =  1  mV,
nd  a ﬁlter  range  from  0.1  to  150  Hz.  The  fQRS  was  deﬁned
s  an  R’,  notching  of  the  R  wave,  notching  of  the  downstroke
r  upstroke  of  the  S  wave,  or  the  presence  of  >1R’  [3].  An
bnormal  Q  wave  was  deﬁned  as  a  wave  of  ≥20  ms  in  dura-
ion  or  a  QS  complex  in  leads  V2—3 and  a  wave  of  ≥30  ms  in
uration  and  ≥1  mm  in  depth  or  a  QS  complex  in  other  leads
9,10].  The  presence  or  absence  of  abnormal  Q  waves  and
QRS  was  determined  by  the  consensus  of  2  observers  who
ere  blinded  to  all  of  the  patients’  clinical  and  angiographic
ata.  Inter-  and  intra-observer  concordance  rates  for  the
umber  of  leads  with  fQRS  in  each  patient  were  97.6%  and
6.5%,  respectively.
tatistical  analysis
ata  are  expressed  as  mean  ±  SD  or  n  (%).  Comparisons  of
ontinuous  variables  were  performed  using  the  unpaired  t
est  or  the  Mann—Whitney  U  test.  Comparisons  of  categor-
cal  variables  were  performed  using  the  chi-square  test.
nivariate  and  multivariate  analyses  using  a  Cox  propor-
ional  hazards  model  were  performed  to  determine  the
redictors  of  the  primary  end  point.  The  following  explana-
ory  variables  were  used  in  the  univariate  analyses:  age,
ale  gender,  body  mass  index,  diabetes  mellitus,  current
moking,  chronic  kidney  disease,  anterior  wall  MI,  multi-
essel  coronary  disease,  LV  ejection  fraction,  number  of
eads  with  abnormal  Q  waves,  number  of  leads  with  fQRS,
oop  diuretic  use,  spironolactone  use,  renin—angiotensin
ystem  inhibitor  (angiotensin-converting  enzyme  inhibitor
r  angiotensin  receptor  blocker)  use,  beta-blocker  use,  and
tatin  use.  Explanatory  variables  with  a  p  value  <0.1  on  the
nivariate  analyses  were  entered  into  a  multivariate  analy-
is.  A  receiver  operating  characteristic  curve  (ROC)  was  used
o  determine  the  best  cut-off  number  of  leads  with  fQRS  for
istinguishing  between  patients  who  developed  the  primary
nd  point  and  those  who  did  not.  The  best  cut-off  number
38  K.  Torigoe  et  al.
Table  1  Baseline  characteristics.
Number  of  patients  170
Age (years)  68.6  ±  9.2
Male gender  136  (80.0)
Body mass  index  (kg/m2)  23.7  ±  3.0
Hypertension  141  (82.9)
Dyslipidemia 141  (82.9)
Diabetes  mellitus 75 (44.1)
Current  smoking 22 (12.9)
Chronic  kidney  disease 82 (48.2)
Anterior  wall  MI  92  (54.1)
Multivessel  coronary  disease  101  (59.4)
Prior percutaneous  coronary  intervention  163  (95.9)
Balloon  angioplasty 137  (80.6)
Stenting  93  (54.7)
Rotablation  13  (7.6)
Prior coronary  artery  bypass  graft  20  (11.8)
Number  of  leads  with  abnormal  Q  waves  2.6  ±  1.9
Number of  leads  with  fQRS  1.9  ±  2.0
LV ejection  fraction  (%)  53.9  ±  14.0
Medications
Aspirin 123 (72.4)
Loop diuretic 38  (22.4)
Spironolactone 28 (16.5)
Calcium  antagonist 79 (46.5)






























































≥3  leads  with  fQRS  than  in  those  with  <3  leads  with  fQRS
(p  <  0.001)  (Fig.  3).  The  event-free  rate  was  also  signiﬁcantly
lower  in  the  former  than  in  the  latter  in  both  patients  with










Number of leads with fQRS = 3




0.0Data are expressed as mean ± SD or n (%).
MI, myocardial infarction; fQRS, fragmented QRS; LV, left ven-
tricular.
as  deﬁned  as  the  point  with  the  highest  sum  of  sensitiv-
ty  and  speciﬁcity.  The  event-free  rate  was  estimated  using
 Kaplan—Meier  analysis,  and  the  event-free  curves  were
hen  compared  using  the  log-rank  test.  A  p-value  <0.05  was
onsidered  to  be  statistically  signiﬁcant.  The  data  analysis
as  carried  out  using  the  SPSS  12.0J  software  program  for
indows  (SPSS  Inc.,  Tokyo,  Japan).
esults
ne  hundred  seventy  patients  (136  males  and  34  females,
ean  age  of  68.6  ±  9.2  years)  were  included  in  this  study.
f  170  patients,  2  could  not  be  followed  up  until  December
1,  2010.  Table  1  shows  the  patient  characteristics  at  base-
ine.  Fig.  1  shows  the  distribution  of  the  number  of  leads
ith  fQRS.  A  fQRS  was  observed  in  ≥1  lead(s)  in  115  (67.6%)
atients.
During  a  mean  follow-up  period  of  6.4  ±  2.9  years,  37
atients  developed  the  primary  end  point:  cardiac  death
n  7  (sudden  death  in  4,  fatal  MI  in  2,  and  ventricular  ﬁb-
illation  in  1)  and  hospitalization  for  heart  failure  in  30
followed  by  death  due  to  heart  failure  during  hospitaliza-
ion  in  10).  Patients  with  the  primary  end  point  had  a larger
umber  of  leads  with  fQRS  than  those  without  (3.5  ±  2.2  vs
.5  ±  1.7,  p  <  0.001).  Table  2  shows  the  results  of  univariate
nd  multivariate  Cox  proportional  hazards  regression  analy-
es.  Univariate  Cox  proportional  hazards  regression  analyses




pigure  1  The  distribution  of  the  number  of  leads  with  frag-
ented  QRS  (fQRS).
nterior  wall  MI,  LV  ejection  fraction,  number  of  leads  with
QRS,  loop  diuretic  use,  and  spironolactone  use  were  signiﬁ-
antly  associated  with  the  primary  end  point.  A  multivariate
ox  proportional  hazards  regression  analysis  showed  that
ge  (hazard  ratio  [HR]  1.09,  95%  conﬁdence  interval  [CI]
.04—1.14,  p  <  0.001)  and  number  of  leads  with  fQRS  (HR
.33,  95%  CI  1.11—1.60,  p  =  0.002)  were  independent  pre-
ictors  of  the  primary  end  point.
The  best  cut-off  number  of  leads  with  fQRS  to  distin-
uish  between  patients  who  developed  the  primary  end
oint  and  those  who  did  not  was  3  (Fig.  2).  This  cut-off
umber  yielded  a  sensitivity  of  70.3%  and  a  speciﬁcity  of
5.2%  for  distinguishing  between  the  2  groups  of  patients.
he  event-free  rate  was  signiﬁcantly  lower  in  patients  withigure  2  A  receiver  operating  characteristic  curve  to  deter-
ine the  best  cut-off  number  of  leads  with  fragmented  QRS
fQRS)  for  distinguishing  between  patients  with  and  without  the
rimary  end  point.
Number  of  leads  with  fragmented  QRS  in  MI  39
Table  2  Univariate  and  multivariate  analyses  using  a  Cox  proportional  hazards  model  to  determine  the  predictors  of  the  primary
end point.
Variable  Univariate  Multivariate
HR  (95%  CI)  p-Value  HR  (95%  CI)  p-Value
Age  (years) 1.10  (1.05—1.15)  <0.001  1.09  (1.04—1.14)  <0.001
Male gender 0.42  (0.21—0.82)  0.01  0.65  (0.30—1.40)  0.27
Body mass  index  (kg/m2)  0.93  (0.84—1.03) 0.16
Diabetes  mellitus 1.43  (0.75—2.72) 0.28
Current  smoking 0.17  (0.02—1.21) 0.08  0.39  (0.05—3.13) 0.38
Chronic kidney  disease  2.66  (1.31—5.38)  0.007  1.51  (0.67—3.36)  0.32
Anterior wall  MI  2.73  (1.29—5.79)  0.009  1.28  (0.52—3.17)  0.60
Multivessel coronary  disease  1.99  (0.96—4.11)  0.06  1.53  (0.69—3.40)  0.30
LV ejection  fraction  (%) 0.95  (0.93—0.97)  <0.001  1.00  (0.96—1.03)  0.74
Number of  leads  with  abnormal  Q  waves  1.12  (0.97—1.29)  0.12
Number of  leads  with  fQRS  1.52  (1.33—1.75)  <0.001  1.33  (1.11—1.60)  0.002
Loop diuretic  6.03  (3.13—11.61)  <0.001  2.54  (0.87—7.44)  0.09
Spironolactone  3.89  (1.99—7.60)  <0.001  1.02  (0.38—2.72)  0.97
Renin—angiotensin  system  inhibitor  0.88  (0.46—1.69)  0.71
Beta-blocker  1.27  (0.66—2.48)  0.48
Statin 0.77  (0.39—1.54)  0.47
HR, hazard ratio; CI, conﬁdence interval; MI, myocardial infarction; fQRS, fragmented QRS; LV, left ventricular.
(n  =  78)  (Fig.  4).  Patients  with  ≥3  leads  with  fQRS  (n  =  59)
had  higher  prevalences  of  anterior  wall  MI,  prior  coronary
artery  bypass  graft,  loop  diuretic  use,  and  spironolactone
use,  a  lower  prevalence  of  calcium  antagonist  use,  greater
numbers  of  leads  with  abnormal  Q  waves,  and  lower  LV  ejec-
tion  fractions  than  those  with  <3  leads  with  fQRS  (n  =  111)
(Table  3).
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Figure  3  The  Kaplan—Meier  primary  event-free  curves  for
patients  with  ≥3  leads  with  fragmented  QRS  (fQRS)  and  those
































o  the  best  of  our  knowledge,  this  is  the  ﬁrst  study  that  has
xamined  the  prognostic  signiﬁcance  of  the  number  of  leads
ith  fQRS  in  patients  with  prior  MI.
The  presence  of  fQRS  in  ≥2  contiguous  leads  correspond-
ng  to  a  major  coronary  artery  territory  on  the  12-lead
lectrocardiogram  has  been  shown  to  predict  cardiac  events
n  patients  with  coronary  artery  disease  [4],  all-cause  mor-
ality  in  those  with  acute  coronary  syndrome  [5],  cardiac
vents  in  those  with  prior  MI  showing  resolved  Q  waves  [6],
nd  all-cause  mortality  and  arrhythmic  events  in  those  with
schemic  or  non-ischemic  cardiomyopathy  [7].  It  has  been
onsidered  that  fQRS  results  from  the  presence  of  signiﬁcant
yocardial  necrosis,  with  islands  of  viable  myocardial  tissue
nterspersed  in  abundant  ﬁbrous  tissue  in  coronary  artery
isease  [11]. It  would  be  expected  that  a  larger  number
f  fQRS  may  be  associated  with  a  larger  size  of  myocardial
cars  [3,12], a  more  depressed  LV  systolic  function  [12], and
ntraventricular  systolic  dyssynchrony  [13]. We  thus  hypoth-
sized  that  a  larger  number  of  leads  with  fQRS  would  be
ssociated  with  cardiac  death  or  hospitalization  for  heart
ailure  in  patients  with  prior  MI.  In  the  present  study,  the
umber  of  leads  with  fQRS  was  signiﬁcantly  higher  in  MI
atients  who  developed  cardiac  death  or  hospitalization  for
eart  failure  than  in  those  who  did  not.  A  multivariate  Cox
roportional  hazards  regression  analysis  selected  the  num-
er  of  leads  with  fQRS  as  one  of  the  independent  predictors
or  cardiac  death  or  hospitalization  for  heart  failure.  These
ndings  suggest  that  the  number  of  leads  with  fQRS  pro-
ides  useful  prognostic  information  for  patients  with  prior
I.  Furthermore,  in  the  present  study,  the  event-free  rate
as  signiﬁcantly  lower  in  patients  with  ≥3  leads  with  fQRS
40  K.  Torigoe  et  al.
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pigure  4  The  Kaplan—Meier  primary  event-free  curves  for  pa
eads with  fQRS  in  those  with  anterior  wall  myocardial  infarctio
han  in  those  with  <3  leads  with  fQRS  in  each  group  of  all
atients,  those  with  anterior  wall  MI,  or  those  with  non-
nterior  wall  MI.  This  cut-off  number  of  leads  with  fQRS
ill  need  to  be  validated  in  prospective  studies  with  a  large
ample  size.
Because  the  myocardial  scar  can  serve  as  an  arrhythmo-
enic  substrate  in  patients  with  prior  MI,  a  larger  number  of
eads  with  fQRS  may  indicate  a  high  risk  for  sudden  death  due




Table  3  Comparison  of  baseline  characteristics  between  patient
Variable  ≥3  leads  with  fQR
Age  (years)  69.7  ±  9.6  
Male gender  47  (79.7)  
Body mass  index  (kg/m2)  23.6  ±  3.0  
Hypertension  50  (84.7)  
Dyslipidemia  49  (83.1)  
Diabetes mellitus  31  (52.5)  
Current smoking  4  (6.8)  
Chronic kidney  disease  34  (57.6)  
Anterior wall  MI  39  (66.1)  
Multivessel coronary  disease  38  (64.4)  
Prior percutaneous  coronary  intervention  57  (96.6)  
Prior coronary  artery  bypass  graft  11  (18.6)  
Number of  leads  with  abnormal  Q  waves 3.3  ±  2.1  
LV ejection  fraction  (%) 44.9  ±  13.0  
Medications
Aspirin 43 (72.9)  
Loop diuretic  26  (44.1)  
Spironolactone  18  (30.5)  
Calcium antagonist  21  (35.6)  
Renin—angiotensin  system  inhibitor  36  (61.0)  
Beta-blocker  25  (42.4)  
Statin 39  (66.1)  
Data are expressed as mean ± SD or n (%).
MI, myocardial infarction; fQRS, fragmented QRS; LV, left ventricular.s  with  ≥3  leads  with  fragmented  QRS  (fQRS)  and  those  with  <3
I)  (A)  and  those  with  non-anterior  wall  MI  (B).
hat  the  presence  of  fQRS  in  ≥2  contiguous  leads  was  an
ndependent  predictor  of  arrhythmic  events  in  patients  with
schemic  or  non-ischemic  cardiomyopathy  who  received  an
mplantable  cardioverter-deﬁbrillator.  In  contrast,  Cheema
t  al.  [14]  found  no  signiﬁcant  association  between  the
resence  of  fQRS  in  ≥2  contiguous  leads  and  arrhythmic
ortality  in  ischemic  or  non-ischemic  cardiomyopathy.  In
he  present  study,  we  could  not  analyze  the  association
etween  the  number  of  leads  with  fQRS  and  arrhythmic
s  with  ≥3  leads  with  fQRS  and  those  with  <3  leads  with  fQRS.
S  (n  =  59)  <3  leads  with  fQRS  (n  =  111)  p-Value
68.0  ±  9.0  0.23
88  (79.3)  0.95
23.8  ±  3.0  0.73
91  (82.0)  0.65
92  (82.9)  0.98
44  (39.6)  0.11
18  (16.2)  0.10
48  (43.2)  0.07
53  (47.7)  0.02
63  (56.8)  0.33
106  (95.5)  0.99
9  (8.1)  0.04
2.2  ±  1.8  0.001
58.7  ±  12.1  <0.001
80  (72.1)  0.91
12  (10.8)  <0.001
10  (9.0)  <0.001
58  (52.3)  0.04
58  (52.3)  0.27
32  (28.8)  0.08
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mortality  because  of  the  small  number  of  patients  with  def-
inite  arrhythmic  death  (n  =  1).  Whether  the  number  of  leads
with  fQRS  is  associated  with  arrhythmic  deaths  in  patients
with  prior  MI  will  need  to  be  investigated  in  prospective
studies  with  a  larger  number  of  patients.
In  the  present  study,  the  number  of  leads  with  abnormal  Q
waves  was  not  associated  with  cardiac  death  or  hospitaliza-
tion  for  heart  failure.  This  might  be  because  an  abnormal  Q
wave  is  an  insensitive  marker  of  myocardial  scars  [15—17].
A  recent  study  reported  that  the  number  of  leads  with  Q
waves  after  primary  percutaneous  coronary  intervention  for
ST-segment  elevation  acute  MI  was  a  strong  predictor  of
mortality  [18]. However,  the  deﬁnition  of  Q  waves  used  in
that  study  (an  initial  negative  deﬂection  ≥0.1  mV  in  a  lead
with  ST-segment  elevation  ≥0.1  mV  on  the  initial  electro-
cardiogram)  was  different  from  the  standard  deﬁnition  of
abnormal  Q  waves  [9],  which  was  used  in  the  present  study.
Study  limitations
The  present  study  has  a  few  limitations.  First,  this  was  a
retrospective  study  that  included  a  relatively  small  num-
ber  of  patients  with  prior  MI.  Therefore,  the  results  of
the  present  study  will  need  to  be  validated  in  prospective
studies  including  a  large  sample  size.  Second,  the  preva-
lence  of  beta-blocker  use  and  renin—angiotensin  inhibitor
use  at  baseline  was  not  high  in  the  present  study,  although
some  patients  started  treatment  with  these  agents  dur-
ing  the  follow-up  period.  Therefore,  the  results  of  the
present  study  may  not  be  applicable  to  patients  with  prior
MI  who  undergo  optimal  pharmacological  treatment.  Third,
the  present  study  excluded  patients  with  bundle  branch
block.  Fragmented  wide  QRS  was  previously  reported  to
be  an  independent  predictor  of  mortality  in  patients  with
known  or  suspected  coronary  artery  disease  [19]. The  prog-
nostic  signiﬁcance  of  the  number  of  leads  with  fragmented
wide  fQRS  will  need  to  be  clariﬁed  in  patients  with  prior  MI.
Finally,  further  studies  with  a  large  sample  size  are  needed
to  determine  whether  the  number  of  leads  with  fQRS  is  a
more  useful  index  for  predicting  cardiac  death  or  hospital-
ization  for  heart  failure  in  patients  with  prior  MI  than  other
electrocardiographic  indices  including  Selvester  score.
Conclusions
The  present  study  is  the  ﬁrst  to  show  the  number  of  leads
with  fQRS,  especially  the  presence  of  ≥3  leads  with  fQRS,
to  be  independently  associated  with  cardiac  death  or  hospi-
talization  for  heart  failure  in  patients  with  prior  MI.
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